The Latest Cancer Drugs News

The Latest Cancer Drugs News
The Institute of Cancer Research, London, UK, has welcomed the announcement by NICE that it…
Bristol Myers Squibb (NYSE: BMY) announced that the European Commission (EC) has approved Opdivo (nivolumab)…
While proteins on the surface of cells are the targets for most drugs, refined methods…
Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines,…
With the advent of pharmacogenomics, machine learning research is well underway to predict the patients’…
Many patients with pancreatic cancer have only about a 10% chance of survival within five…
A group of Moscow scientists has discovered and explained the activity mechanism of a new…
A new drug designed to counter the effects of an important, but very hard to…
Major changes to the way immunotherapy drugs are researched and evaluated are essential if they…
Younger patients with resected melanoma had some benefit from adjuvant treatment with the anti-VEGF therapeutic…